These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8977767)

  • 1. Transformation but not ras-transfection increases the expression of galectin-3 in human HOS cells.
    Hébert E; Roche AC; Nachtigal M; Monsigny M
    C R Acad Sci III; 1996 Oct; 319(10):871-7. PubMed ID: 8977767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.
    Paz A; Haklai R; Elad-Sfadia G; Ballan E; Kloog Y
    Oncogene; 2001 Nov; 20(51):7486-93. PubMed ID: 11709720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
    Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
    Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
    Gong HC; Honjo Y; Nangia-Makker P; Hogan V; Mazurak N; Bresalier RS; Raz A
    Cancer Res; 1999 Dec; 59(24):6239-45. PubMed ID: 10626818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 mRNA level depends on transformation phenotype in ras-transformed NIH 3T3 cells.
    Hébert E; Monsigny M
    Biol Cell; 1994; 81(1):73-6. PubMed ID: 7987244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
    Mazurek N; Sun YJ; Price JE; Ramdas L; Schober W; Nangia-Makker P; Byrd JC; Raz A; Bresalier RS
    Cancer Res; 2005 Dec; 65(23):10767-75. PubMed ID: 16322222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter.
    Kadrofske MM; Openo KP; Wang JL
    Arch Biochem Biophys; 1998 Jan; 349(1):7-20. PubMed ID: 9439577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.
    Kim HR; Lin HM; Biliran H; Raz A
    Cancer Res; 1999 Aug; 59(16):4148-54. PubMed ID: 10463621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumor growth by galectin-7 gene transfer.
    Ueda S; Kuwabara I; Liu FT
    Cancer Res; 2004 Aug; 64(16):5672-6. PubMed ID: 15313906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
    Inohara H; Akahani S; Koths K; Raz A
    Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells.
    Sriadibhatla S; Yang Z; Gebhart C; Alakhov VY; Kabanov A
    Mol Ther; 2006 Apr; 13(4):804-13. PubMed ID: 16199206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-Ras promotes tumor growth of cervical epithelial cells.
    Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
    Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes.
    Joo HG; Goedegebuure PS; Sadanaga N; Nagoshi M; von Bernstorff W; Eberlein TJ
    J Leukoc Biol; 2001 Apr; 69(4):555-64. PubMed ID: 11310841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.